Pharma Stocks
-
Sun Pharma Q1 Results: Stock falls 3% from highs after US sales miss expectations
Sun Pharma shares declined as much as 3% from the highs of the day on Friday, July 31, after the…
Read More » -
Pharma Mar (BME:PHM) Stock Faces Clinical Setback Despite Royalty Strength
Pharma Mar stock closed at €80.15 after the market absorbed its half year 2026 update, leaving investors weighing a flat…
Read More » -
Vertex Just Paid $10 Billion for Crinetics. Here’s Why Viking Therapeutics Could Be the Next Big Pharma Takeover Target
This has been an active year in the mergers-and-acquisitions landscape across the biopharmaceutical industry. One of the more notable deals…
Read More » -
Strong Revenue Growth and …
This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings call, please…
Read More » -
Will Generic Drug Tariffs Impact Pharma ETFs? – July 30, 2026
Key Takeaways Trump’s phased generic drug tariffs could raise costs and medicine prices. Pharma ETFs may see volatility as tariff…
Read More » -
Amneal Pharmaceuticals (AMRX) Wins FDA Nod For Iohexol, Is The Upside Already Priced In?
Amneal Pharmaceuticals (AMRX) has drawn fresh attention after receiving U.S. Food and Drug Administration approval for additional strengths and vial…
Read More » -
Tarsus Pharmaceuticals (TARS) Could Be 38% Undervalued Following Cautious Earnings Expectations
Investors are watching Tarsus Pharmaceuticals (TARS) ahead of its upcoming quarterly report, with expectations for a loss alongside higher revenue…
Read More » -
Roche (SWX:ROP) Wins FDA Clearance And EU Backing For Two Key Products
Roche Holding (SWX:ROP) received FDA 510(k) clearance for its cobas BV/CV molecular diagnostic assay, expanding its sexual health testing portfolio…
Read More » -
Forget Weight Loss Drugs: Here’s Another Reason to Buy Eli Lilly Stock
Eli Lilly (LLY -0.21%) brought in $19.8 billion in revenue in the first quarter of 2026, and most of it…
Read More » -
Is Camurus (OM:CAMX) Still Undervalued On Its FDA CAM2029 Milestone?
Camurus (OM:CAMX) is back in focus after the US Food and Drug Administration accepted the resubmitted New Drug Application for…
Read More »
